Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Neurochemical effects of quetiapine in patients with bipolar mania: a proton magnetic resonance spectroscopy study.

Adler CM, DelBello MP, Weber WA, Jarvis KB, Welge J, Chu WJ, Rummelhoff E, Kim MJ, Lee JH, Strakowski SM.

J Clin Psychopharmacol. 2013 Aug;33(4):528-32. doi: 10.1097/JCP.0b013e3182905b77.

PMID:
23764689
2.

Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.

Chang K, Delbello M, Chu WJ, Garrett A, Kelley R, Mills N, Howe M, Bryan H, Adler C, Eliassen J, Spielman D, Strakowski SM.

J Child Adolesc Psychopharmacol. 2012 Aug;22(4):261-8. doi: 10.1089/cap.2011.0153.

3.

Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.

DelBello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM.

Neuropsychopharmacology. 2006 Jun;31(6):1264-73.

4.

Neurofunctional effects of quetiapine in patients with bipolar mania.

Davis AK, DelBello MP, Eliassen J, Welge J, Blom TJ, Fleck DE, Weber WA, Jarvis KB, Rummelhoff E, Strakowski SM, Adler CM.

Bipolar Disord. 2015 Jun;17(4):444-9. doi: 10.1111/bdi.12274.

PMID:
25359589
5.

Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.

Strawn JR, Patel NC, Chu WJ, Lee JH, Adler CM, Kim MJ, Bryan HS, Alfieri DC, Welge JA, Blom TJ, Nandagopal JJ, Strakowski SM, DelBello MP.

J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):642-51. doi: 10.1016/j.jaac.2012.03.009.

6.

Cortical neurochemistry in euthymic patients with bipolar I disorder.

Scherk H, Backens M, Schneider-Axmann T, Usher J, Kemmer C, Reith W, Falkai P, Gruber O.

World J Biol Psychiatry. 2009;10(4):285-94. doi: 10.3109/15622970701472086.

PMID:
19921970
7.

Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.

Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E.

Psychol Med. 2007 Jan;37(1):121-9.

PMID:
17094813
8.

Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium.

Patel NC, DelBello MP, Cecil KM, Stanford KE, Adler CM, Strakowski SM.

J Child Adolesc Psychopharmacol. 2008 Apr;18(2):132-9. doi: 10.1089/cap.2007.0088.

PMID:
18439111
9.

N-acetylaspartate normalization in bipolar depression after lamotrigine treatment.

Croarkin PE, Thomas MA, Port JD, Baruth JM, Choi DS, Abulseoud OA, Frye MA.

Bipolar Disord. 2015 Jun;17(4):450-7. doi: 10.1111/bdi.12285.

10.

Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.

Hajek T, Bauer M, Pfennig A, Cullis J, Ploch J, O'Donovan C, Bohner G, Klingebiel R, Young LT, Macqueen GM, Alda M.

J Psychiatry Neurosci. 2012 May;37(3):185-92. doi: 10.1503/jpn.110097.

11.

Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine.

Atmaca M, Ozdemir H, Cetinkaya S, Parmaksiz S, Belli H, Poyraz AK, Tezcan E, Ogur E.

J Psychiatr Res. 2007 Nov;41(10):821-7.

PMID:
16950400
12.

Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients.

Sassi RB, Stanley JA, Axelson D, Brambilla P, Nicoletti MA, Keshavan MS, Ramos RT, Ryan N, Birmaher B, Soares JC.

Am J Psychiatry. 2005 Nov;162(11):2109-15.

PMID:
16263851
13.

A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.

Frey BN, Folgierini M, Nicoletti M, Machado-Vieira R, Stanley JA, Soares JC, Kapczinski F.

Hum Psychopharmacol. 2005 Mar;20(2):133-9.

PMID:
15648094
14.

Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.

Suppes T, Kelly DI, Keck PE Jr, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H.

Int Clin Psychopharmacol. 2007 Nov;22(6):376-81.

PMID:
17917557
15.

Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.

Patel NC, Cecil KM, Strakowski SM, Adler CM, DelBello MP.

J Child Adolesc Psychopharmacol. 2008 Dec;18(6):623-7. doi: 10.1089/cap.2007.151.

16.
17.

Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.

Zhong S, Wang Y, Zhao G, Xiang Q, Ling X, Liu S, Huang L, Jia Y.

J Affect Disord. 2014 Oct;168:380-6. doi: 10.1016/j.jad.2014.07.024.

PMID:
25106035
18.

1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.

Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer D, Keshavan MS, Soares JC.

J Affect Disord. 2005 May;86(1):61-7.

PMID:
15820271
19.

Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.

Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.

Clin Ther. 2011 Nov;33(11):1643-58. doi: 10.1016/j.clinthera.2011.10.002.

PMID:
22054797
20.
Items per page

Supplemental Content

Support Center